NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Genre Technical Report ✖Remove constraint Genre: Technical Report Publication Year 2021 ✖Remove constraint Publication Year: <span class="single" data-blrl-single="2021">2021</span>

622. States’ backlogs of standard surveys of nursing homes grew substantially during the COVID-19 pandemic

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2021
Subject(s):
Government Regulation
Health Care Surveys -- statistics & numerical data
Nursing Homes -- legislation & jurisprudence
COVID-19
United States
United States. Department of Health and Human Services

623. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):
Drug Development -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Medicare Part D -- economics
Orphan Drug Production -- economics
United States
United States. Department of Health and Human Services

624. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021
Subject(s):
Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

626. SAMHSA is missing opportunities to better monitor access to medication-assisted treatment through the buprenorphine waiver program

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2021
Subject(s):
United States Substance Abuse and Mental Health Services Administration
Buprenorphine -- supply & distribution
Government Regulation
Opioid Epidemic
United States
United States. Department of Health and Human Services

627. Concerns persist about opioid overdoses and Medicare beneficiaries’ access to treatment and overdose-reversal drugs

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2021
Subject(s):
Government Regulation
Medicare Part D -- statistics & numerical data
Naloxone -- economics
Opiate Overdose -- prevention & control
United States
United States. Department of Health and Human Services

628. Characteristics of separated children in ORR’s care: June 27, 2018–November 15, 2020

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, November 2021
Subject(s):
Child Health -- legislation & jurisprudence
Government Regulation
Refugees -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

630. Some Medicare Advantage companies leveraged chart reviews and health risk assessments to disproportionately drive payments

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):
Government Regulation
Health Status Indicators
Insurance Carriers -- legislation & jurisprudence
Medical Records -- economics
Medicare Part C -- economics
Quality of Health Care -- legislation & jurisprudence
United States
United States. Department of Health and Human Services